NEW

Legent Imaging Increases Revenue, Decreases Rejected Claims

Konica Minolta Healthcare Americas, Inc. announced today the implementation of Exa® PACS/RIS/Billing and the company’s Revenue Cycle Management (RCM) solution, provided by All Covered, Konica Minolta Business Solutions U.S.A., Inc.'s IT Services Division, at Legent...

Stryker Launches Q Guidance System with Spine Guidance Software

Stryker has unveiled its Q Guidance System for spine applications. The system combines new optical tracking options provided by a redesigned, state-of-the-art camera with sophisticated algorithms of the newly launched Spine Guidance Software to deliver more surgical...

FDA Approves Gadopiclenol Injection for U.S. Market

Bracco Diagnostics Inc., the United States (U.S.) subsidiary of Bracco Imaging S.p.A., an innovative world leader in diagnostic imaging, announced that the U.S. Food and Drug Administration (FDA) has approved Gadopiclenol Injection, a new, highly stable macrocyclic...

Fujifilm Upgrades ASGE’s Institute for Training and Technology with State-of-the-Art Endoscopic Imaging Solutions

FUJIFILM Healthcare Americas Corporation and the American Society for Gastrointestinal Endoscopy (ASGE) announce that ASGE has equipped its Chicago-based Institute for Training and Technology (IT&T) Advanced Bioskills Laboratory and Simulation Center with 16 of...

Joint Commission Issues Statement on Standards Review

The Joint Commission President and Chief Executive Officer Jonathan B. Perlin, MD, Ph.D., MSHA, MACP, FACMI, shared the following information on September 13, 2022.

Today we announced the beginning of a review of all Joint Commission “above-and-beyond” requirements, those that go beyond the Centers for Medicare & Medicaid Services (CMS) Conditions of Participation (CoPs) and are not on crosswalks to the CoPs.

During the COVID-19 public health emergency (PHE), CMS put many requirements on hold. As the PHE nears its end, CMS has been reviewing the waived requirements to determine whether some should be permanently retired. The Joint Commission will similarly address the necessity of our own unique requirements.

Specifically, we will review each requirement to answer:

  • Does the requirement still address an important quality and safety issue?
  • Is the requirement redundant?
  • Are the time and resources needed to comply with the requirement commensurate with the estimated benefit to patient care and health outcomes?

In addition to a direct review of each requirement, we will conduct quantitative analyses of scoring patterns and tests for redundancy. Where necessary, we also will conduct literature and field reviews and engage experts within the field.

American health care still has a long way to go to fully recover from COVID-19 and to reach a new equilibrium – especially as we are now witnessing secondary effects from the pandemic. At The Joint Commission, we are committed to working with health care organizations and other stakeholders to help address the many challenges health care is facing, as well as to making our own requirements as efficient and impactful on patient safety and quality as possible.

For more information, visit jointcommission.org.

Previous

Next

Submit a Comment

Your email address will not be published.